Obesity Clinical Trials: Advancing Weight Management Solutions
Obesity affects over 650 million adults globally, posing a significant challenge to health systems and individuals alike. It contributes to life-threatening conditions such as diabetes, cardiovascular disease, and even certain cancers. While managing obesity requires a multifaceted approach, obesity clinical trials are at the forefront of uncovering innovative solutions for prevention, treatment, and long-term weight management. At FOMAT Medical Research, we are dedicated to transforming the future of obesity treatment. By collaborating with sponsors, patients, and healthcare providers, we aim to develop cutting-edge therapies that tackle this epidemic head-on. This page provides a detailed overview of obesity clinical trials, their importance, and how you can participate or contribute to this groundbreaking field of research.
Understanding Obesity and Its Health Impact
What is Obesity?
Obesity is a complex chronic disease characterized by excessive body fat. It is commonly measured using Body Mass Index (BMI), calculated as weight (kg) divided by height squared (m²). Individuals with a BMI of 30 or higher are classified as obese. However, BMI alone does not paint the full picture. Factors such as fat distribution, muscle mass, and metabolic health also play a critical role in determining the severity of obesity and its associated risks.
Types of Obesity:
- Visceral Fat Obesity: Fat stored around internal organs, leading to increased risks of diabetes and cardiovascular issues.
- Subcutaneous Fat Obesity: Fat stored beneath the skin, often less harmful but still associated with chronic conditions.
Obesity is influenced by a combination of factors, including genetics, lifestyle, environment, and psychological health. Recognizing this complexity is essential for designing effective treatments.
Health Risks Associated with Obesity
Obesity significantly increases the risk of several chronic illnesses, including:
Excess fat disrupts insulin regulation, leading to elevated blood sugar levels.
 Obesity contributes to hypertension, high cholesterol, and heart disease.
Increased rates of breast, colon, and endometrial cancers are associated with obesity.
Fat deposits around the neck can obstruct airways, causing disrupted sleep.
Depression, anxiety, and low self-esteem are common among individuals struggling with obesity.
What Are Obesity Clinical Trials?
Phases of Obesity Clinical Trials
Obesity clinical trials are conducted in distinct phases, each designed to test specific aspects of a treatment:
Phase I
Evaluates the safety of a new treatment in a small group of participants, focusing on side effects and appropriate dosages
Phase II
Tests the effectiveness of the treatment on individuals with obesity, gathering data on how it impacts weight loss and overall health
Phase III
Compares the treatment to existing options in a larger, more diverse group of participants
Phase IV
Examines the long-term effects and safety of the treatment after it has been approved for public use
Benefits of Participating in Obesity Clinical Trials
Participating in obesity clinical trials offers several advantages for individuals seeking better weight management options
Access to Cutting-Edge Treatments:
Participants may receive experimental therapies not yet available to the public, offering new hope for weight loss.
Comprehensive Health Monitoring:
Clinical trials provide regular check-ups and diagnostic tests, ensuring participants’ health is closely monitored.
Contribution to Scientific Progress:
By participating, individuals help researchers uncover solutions that could benefit millions worldwide.
Supportive Resources:
Many trials provide dietary counseling, exercise guidance, and mental health support as part of the study protocol.
Current Research and Innovations in Obesity Treatment
Obesity research is constantly evolving, with exciting advancements across multiple areas:
- Drug Development: Medications like Zepbound focus on hormonal pathways to regulate appetite and improve metabolic rates.
- Biological Therapies: These treatments target specific biological processes, such as fat storage and energy balance, to achieve sustained weight loss.
- Lifestyle Interventions: Comprehensive programs that combine diet, exercise, and behavioral therapy are being refined to support long-term success.
- Surgical Innovations: Procedures like gastric sleeve and bypass surgery are being improved for safety and efficacy, with reduced recovery times.
- Future Trends: Gene therapy and microbiome-based treatments are emerging as potential game-changers in the field of obesity management.
Our Active Studies
-
NASH/MASH Trial
NASH/MASH, often a silent liver condition, typically remains undetected until it becomes advanced. It begins with an accumulation of fat in the liver and can progress to significant liver injury. Taking early measures is crucial to curb its severity.  Criteria & Qualifications: • Participants need to be aged 18 or older.
Read more
• Must have a diagnosis of Fatty Liver Disease.
 Compensation: Contact us for more information. -
Ulcerative Colitis
Ulcerative Colitis, a form of Inflammatory Bowel Disease (IBD), leads to inflammation, ulcers, and stomach discomfort. We are currently running a clinical study to test the effectiveness and safety of a new Alfa Induction Therapy for individuals suffering from Ulcerative Colitis.
Read more
Criteria & Qualifications: • Must be 18 years old or above.
• Recently diagnosed with Ulcerative Colitis within the past 3 months.
• Agreeable to submit medical history documentation.
Compensation: Contact us for more information -
Pneumococcal Vaccine
Join our pivotal study to evaluate the Pneumococcal conjugate vaccine in infants and toddlers and help enhance preventive medicine for children.
Read more
Criteria & Qualifications: • Open to all healthy young children.
• Requires consent from a guardian.
• Must attend every scheduled visit.
Compensation: Contact us for more information -
Pneumococcal Vaccine
Coming Soon! Support pediatric wellness by participating in our research on the Pneumococcal conjugate vaccine for young children. Join us in improving preventive health care.
Read more
Criteria & Qualifications: • Applicable to healthy infants and toddlers.
• Parental consent required.
• Availability for all planned visits essential.
Compensation: Contact us for more information -
Pneumococcal Vaccine
Contribute to pediatric vaccine research by enrolling your infant or toddler in our Pneumococcal conjugate vaccine study. Participate in shaping the future of disease prevention.
Read more
Criteria & Qualifications: • Open to healthy infants and toddlers.
• Guardian consent required for participation.
• Must be available for all study appointments.
Compensation: Contact us for more information -
Pneumococcal Vaccine
Help advance pediatric health by joining our study on the Pneumococcal conjugate vaccine for infants and toddlers. Your participation could lead to better preventative care.
Read more
Criteria & Qualifications: • Healthy infants and toddlers eligible.
• Must have guardian consent to participate.
• Able to attend all scheduled study visits.
Compensation: Contact us for more information -
Thyroid Eye Disease
Join our study to explore innovative treatments for Thyroid Eye Disease. Your participation could help improve outcomes and advance research in eye health.
Read more
Criteria & Qualifications: • Diagnosed with Thyroid Eye Disease.
• At least 18 years old, able to consent.
• Able to attend all required study visits.
Compensation: Contact us for more information -
Solid Tumor
Support groundbreaking research by participating in our Solid Tumor study. Your involvement could help develop innovative treatments and improve cancer care. Criteria & Qualifications: • Diagnosed with cancer and not responding to therapy. • Aged 18 or older, able to give consent. • Committed to attend all study visits. Compensation: Contact us for more information
Read more
Understanding the Criteria for Enrolling in Obesity Clinical Trials
Eligibility Requirements
To participate in an obesity clinical trial, individuals must meet specific criteria, which often include:
- BMI Thresholds: Many trials require participants to have a BMI of 30 or higher.
- Health Conditions: Some trials focus on individuals with obesity-related diseases, such as diabetes or high blood pressure.
- Willingness to Follow Protocols: Participants must commit to regular visits, monitoring, and adherence to the study’s requirements.
Clinical trials often prioritize diversity to ensure treatments are effective across different populations.
FOMAT Medical Research’s Commitment to Obesity Clinical Trials
At FOMAT Medical Research, we are passionate about advancing obesity research. Our commitment includes:
Â
- Conducting ethical and innovative clinical trials that prioritize patient safety.
- Partnering with sponsors to optimize trial design and execution.
- Recruiting diverse participants to ensure research findings are inclusive and applicable to real-world populations.
We have conducted numerous successful trials, contributing valuable insights to the field of obesity management.
Frequently Asked Questions
Emerging treatments like Zepbound are designed to target hormones that regulate metabolism and appetite, offering new hope for individuals struggling with weight loss.
Clinical tests for obesity typically involve BMI measurements, metabolic screenings, and assessments of obesity-related health conditions.
The success of obesity treatments varies, but a combination of lifestyle changes, medications, and surgical interventions often yields the best results.
The duration of obesity clinical trials varies depending on the study’s goals and phase. Early-phase trials may last a few months, while later-phase or long-term studies can span several years. Researchers provide detailed timelines during the enrollment process.
Safety is a top priority in clinical trials. Each study is carefully reviewed by regulatory bodies and ethics committees to ensure that participants are protected. Additionally, participants receive ongoing monitoring to address any concerns that arise during the trial.
Eligibility depends on the trial’s focus. Most studies require participants to meet specific BMI thresholds and may include other criteria, such as obesity-related health conditions or age restrictions.
Yes, there are trials specifically designed for children and adolescents to address the unique factors contributing to obesity in younger populations. These studies often focus on behavioral and lifestyle interventions tailored to their developmental needs.
Many clinical trials offer compensation to participants for their time, travel, and other expenses. Specific details about compensation are provided during the enrollment process.
Join FOMAT in Advancing Obesity Research
Obesity is one of the most pressing health challenges of our time, but together, we can make a difference. At FOMAT Medical Research, we are committed to addressing this epidemic through innovative clinical trials that pave the way for groundbreaking treatments. Whether you are a patient seeking new weight management solutions, a sponsor looking to advance medical research, or a healthcare provider eager to make an impact, there is a role for you in the fight against obesity.
By participating in or supporting obesity clinical trials, you not only gain access to cutting-edge therapies but also contribute to a global effort to improve lives. The data collected through these trials will shape the future of obesity management, making treatments safer, more effective, and accessible to those who need them most.
Don’t wait to take the first step toward a healthier future. Contact us today to learn more about current opportunities in obesity research and how you can help drive meaningful change. Together, we can achieve a healthier world.